GNA Vodafone Foundation donates PPE to Accra Regional Hospital GNA Koforidua Regional hospital offers free cataract surgery GNA NPP’s side constitutes the Majority in Parliament-Speaker Bagbin APS COVID-19 : SUSPENSION DES VISITES AUX DÉTENUS À PARTIR DE LUNDI APS KAOLACK : LES AUTORITÉS SANS NOUVELLES DE 33 PERSONNES POSITIVES À LA COVID-19 APS BAISSE DES INDICATEURS LIÉS AUX ACCIDENTS DE LA CIRCULATION À FATICK (SAPEURS-POMPIERS) AIP International/ Mastercard Global Outlook 2021 souligne la transition permanente vers le numérique (Rapport) AIP Un nouveau DGA au DC/BR de l’UEMOA AIP Législatives 2021: Le RHDP peine à désigner un candidat à Grabo AIP Inter/ Le SG de l’ONU nomme la Guinéenne Bintou Kéita à la tête de sa mission en RDC

British regulator authorizes use of AstraZeneca/Oxford vaccine


  30 Décembre      15        Santé (8578),

   

London, Dec. 30, (dpa/GNA) – Britain’s Medicines and Healthcare products Regulatory Agency (MHRA) has authorized the use of the vaccine developed by AstraZeneca and Oxford University, the government says.
« Now the NHS will begin putting their extensive preparations into action to roll out the Oxford University/AstraZeneca vaccine, » says the government statement.
The vaccine is the second to be approved for usage in Britain.
The Pfizer/BioNTech vaccine was the first jab given the green light in Britain by the MHRA on December 2 and began being rolled out to vulnerable and elderly people the following week.
« With two vaccines now approved, we will be able to vaccinate a greater number of people who are at highest risk, protecting them from the disease and reducing mortality and hospitalisation, » adds the statement.
GNA

Dans la même catégorie